Qatar German For Medical Devices

As of June 30, 2026, Qatar German For Medical Devices carries a market capitalization of 160.66M, placing it among publicly traded companies globally. Its enterprise value stands at 301.66M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Qatar German For Medical Devices has 115.50M shares outstanding.

As of June 30, 2026, Qatar German For Medical Devices trades at a trailing price-to-earnings ratio of 70.94. The price-to-sales ratio is 28.96, and the price-to-book ratio stands at -6.52.

These figures are as of June 30, 2026. The EV/Sales ratio of 54.41 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 301.66M versus a market cap of 160.66M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Qatar German For Medical Devices maintains a current ratio of 0.87, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -573.74, indicating conservative leverage, while an interest coverage ratio of -6.94 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on invested capital (ROIC) is negative at -12.71, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) stands at 1.67, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 2.44, useful for judging operating efficiency across full business cycles. Inventory turnover of 0.23 indicates how many times Qatar German For Medical Devices sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Qatar German For Medical Devices's stock has declined approximately 21.03% over the past 52 weeks. The 50-day moving average sits at 1.31, while the 200-day moving average is 1.39.

Over the twelve months ended June 30, 2026, Qatar German For Medical Devices generated 5.54M in revenue and converted that into 2.26M in net income, yielding earnings per share of 0.02. EBITDA reached -3.96M, while operating income came in at -6.45M.

As of June 30, 2026, Qatar German For Medical Devices holds 388,638.00 in cash and equivalents against 141.39M in total debt, resulting in a net debt position of 140.96M. Total book value stands at -24.64M, with working capital of -2.79M providing operational flexibility.

Over the twelve months ended June 30, 2026, Qatar German For Medical Devices posted a gross margin of 36.81, reflecting its pricing power and cost economics. The operating margin of -116.35 and net profit margin of 40.83 provide insight into operational efficiency.

Qatar German For Medical Devices's most recent stock split took place on June 19, 2019 with a 1:10 split ratio.

As of June 30, 2026, Qatar German For Medical Devices has an Altman Z-Score of -1.62, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.